Author: Mentavi Health

Built for trust and compliance, the AI support assistant streamlines intake and routes visitors and patients to human‑led care.

GRAND RAPIDS, MICHIGAN / ACCESS Newswire / November 11, 2025 / Mentavi Health, a leader in evidence-based digital mental health care, has launched Mentavi Concierge, its next-generation AI support assistant that enhances the digital health journey of visitors and patients while keeping human clinicians at the center of care.

Mentavi Concierge represents the company’s belief in the ethical use of AI: as a powerful tool for access, efficiency, and personalization – but never as a replacement for human clinical judgment or care. Mentavi continues to exclusively use licensed human psychologists for diagnosis and human clinicians for treatment.

“Our leverage of AI is aimed at providing enhanced customer efficiencies and experiences as we continue to scale – and complements, not replaces, the work of our staff,” said Keith Brophy, CEO of Mentavi Health. “This technology, the way we are implementing it, is patient-lifting, not job-replacing.”

Enhancing Patient Access and Confidence

Mentavi Concierge assists individuals at the earliest stage of their mental health journey – when they are exploring services, seeking clarity, and often waiting for human support. It provides immediate, accurate answers to questions such as:

• “What services are available in my state?”

• “How does the diagnostic process work?”

• “What happens if I find out I have ADHD?”

Mentavi Concierge offers patients an interactive, trustworthy experience on the Mentavi website, guiding them toward human-led evaluation and care while staying strictly within regulatory boundaries.

“Patients today want the easy access of online care,” Brophy added. “But they also want the reassurance that committed humans remain front and center. We built Mentavi Concierge to reflect that balance.”

Built for Trust, Safety, and Compliance

Mentavi’s development team designed Mentavi Concierge using proprietary, self-hosted AI infrastructure built on advanced agentic frameworks. The application runs within Mentavi’s HIPAA-compliant environment, avoiding the risks associated with third-party AI integrations.

From the outset, the system was architected with patient safety and regulatory compliance as non-negotiable priorities. Mentavi Concierge does not engage in clinical dialogue, nor does it provide treatment recommendations, and it will defer to Mentavi’s human clinicians for diagnostic and therapeutic guidance.

“We are excited about taking a significant step toward improving healthcare journeys with a responsible AI framework,” said Angie Lillie, chief compliance officer at Mentavi. “This aligns with the growing body of state and federal regulations around the ethical use of AI in healthcare.”

A Proven Foundation of Clinical Rigor

The introduction of Mentavi Concierge follows Mentavi’s recently published peer-reviewed clinical trial in the Journal of Clinical Psychiatry, which validated the company’s asynchronous online diagnostic assessment for ADHD in adults. The study confirmed that Mentavi’s digital-first diagnostic approach delivers outcomes consistent with in-person evaluations – a landmark in the evolution of telehealth standards.

“Technology and human care must evolve together,” said Steve Goulet, VP of product and technology and Chair of Mentavi’s AI Ethics and Governance Committee. “Our long-term vision is to create a seamless, supportive digital experience – where AI enhances, but never replaces, the human connection.”

About Mentavi Health
Founded in 2018 as ADHD Online, and recognized as one of Michigan’s “50 Companies to Watch,” Mentavi Health provides evidence-based, compliant online mental health care nationwide. Its clinically validated Diagnostic Evaluation for diagnosing adult ADHD serves as the foundation for assessing anxiety, depression, OCD, and related conditions. Mentavi delivers affordable, high-quality care through licensed clinicians, offering diagnostic evaluations, therapy, medical treatment, and mental wellness coaching. Guided by clinical rigor, accessibility, compliance, and trust, Mentavi is redefining how people connect to quality mental health care. Learn more at mentavi.com.

Contact Information

Tim Cox
ZingPR for Mentavi Health
tim@zingpr.com

SOURCE: Mentavi Health

Related Images

View the original press release on ACCESS Newswire

Affordable, clinician-reviewed assessments help SBCC reach accommodation decisions sooner and keep students on track during critical academic periods.

GRAND RAPIDS, MI AND SANTA BARBARA, CA / ACCESS Newswire / October 29, 2025 / Santa Barbara City College (SBCC) is adopting Mentavi Health‘s Diagnostic Evaluation to provide timely, rigorous ADHD assessments for students seeking academic accommodations. The partnership enables SBCC to reach accommodation decisions faster, when appropriate, and helps students stay on course during the term’s most demanding weeks.

ADHD is the second-largest eligibility category for SBCC’s Disability Services and Programs for Students (DSPS). Until now, many students have faced weeks-long waits for off-campus diagnostic appointments-delays that can impede access to federally mandated accommodations under the Americans with Disabilities Act (ADA) and Section 504.

With Mentavi’s asynchronous online Diagnostic Evaluation, students can complete a thorough assessment in about 60-90 minutes and receive results, reviewed by a licensed, doctorate-level clinician, within five days. The process reduces turnaround time from weeks to days, while meeting clinical standards for documentation required by DSPS.

“Early identification and treatment of ADHD and related mental-health conditions is crucial for improved academic and personal outcomes,” said Mentavi Health Chief Medical Officer Barry K. Herman, M.D., MMM. “Timely diagnosis enables students to access the accommodations and support they need to succeed.”

Mentavi’s Diagnostic Evaluation, the first online ADHD assessment for adults to be clinically validated against current standards of care, has already served more than a dozen higher-education institutions nationwide and completed over 20,000 college-student evaluations. The validation study was published September 8, 2025, in the Journal of Clinical Psychiatry (J Clin Psychiatry 2025;86(3):25m15846; doi:10.4088/JCP.25m15846).

“For many of our students, the greatest challenge isn’t the classroom itself but the invisible barriers that delay the accommodations they are entitled to under federal law,” said Jana M. Garnett, DSPS Coordinator and Director at SBCC. “Mentavi makes professional clinical diagnoses both accessible and affordable, providing a pathway to the support our students need to thrive.”

Efficient and Affordable Support

Students complete Mentavi’s evaluation online and can share their report with SBCC’s DSPS office to determine accommodations or with a Mentavi clinician for follow-up therapy, medical treatment, or coaching. Each evaluation is reviewed by a licensed clinician-not by automated AI-and is available for $189, a fraction of the cost of typical in-person assessments.

Mentavi’s model helps colleges and universities expand student mental-health support without overburdening campus clinics or budgets, while giving students rapid access to evidence-based care.

Enhancing Student Outcomes and Institutional Reputation

Early, accurate diagnosis equips students to adopt strategies that improve academic performance and personal well-being. By facilitating timely access to care, as indicated by diagnosis, SBCC underscores its commitment to student success and equity.

“With national discussions underway about ADHD treatments and with growing state-level scrutiny of AI in healthcare, Mentavi stands out by combining validated evaluations with a human-centered model,” said Keith Brophy, CEO of Mentavi Health. “Every evaluation is reviewed by a licensed clinician, ensuring accuracy and accountability while reducing stress on families, faculty, and staff.”

About Santa Barbara City College

Established in 1909, Santa Barbara City College (SBCC) is one of the oldest community colleges in California. The district consists of SBCC’s main campus on Santa Barbara’s beachfront coast, two separate campuses for its School of Extended Learning programs, as well as a Cosmetology school. The college offers a range of associate degree, certificate and transfer programs and is recognized by the Department of Education as an official Hispanic-Serving Institution (HSI). One of SBCC student success programs includes the Disability Services and Programs for Students (DSPS). SBCC DSPS ensures educational access through accommodations, services, and support that help students with disabilities achieve their academic goals. Learn more at SBCC.edu.

About Mentavi Health

Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Mental Health Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, compliant online mental health care. For more information, visit mentavi.com.

Media contact:

Tim Cox, ZingPR for Mentavi Health
tim@zingpr.com

SOURCE: Mentavi Health

Related Images

View the original press release on ACCESS Newswire

Open-access publication demonstrates the validity and reliability of the Mentavi online Diagnostic Evaluation compared to a clinical interview, widening evidence based telehealth access for adults with ADHD.

GRAND RAPIDS, MICHIGAN / ACCESS Newswire / October 20, 2025 / Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer reviewed Journal of Clinical Psychiatry (JCP). In what is believed to be the first peer-reviewed study of its kind, an asynchronous, online evaluation matched the diagnostic accuracy of a clinician-led interview for adult ADHD. This publication provides the first peer-reviewed evidence base for a fully digital diagnostic pathway for adult ADHD.

Primary endpoints and results

• n = 345 adults seeking web based ADHD assessment (predominantly female; mean age = 35).

• Sensitivity = 80.6% and Positive Predictive Value = 94.9%.

• False positive rate = 12% versus 56% for the clinical interview, indicating the online tool is accurate in diagnosing ADHD in adults.

• Note: the full article is freely available via the Journal of Clinical Psychiatry (DOI below).

Why it matters

The findings address concerns about rigor in digital diagnostics by showing that an asynchronous, clinician reviewed online pathway can perform comparably on key performance metrics to a structured face-to-face clinical interview conducted via video-while being more conservative in assigning ADHD negative diagnoses.

Study design

The prospective, real-world observational study compared the Mentavi Diagnostic Evaluation-a self-paced, asynchronous questionnaire interpreted by a doctorate level psychologist-with a structured face-to-face clinical interview conducted via video. Primary endpoints were sensitivity, specificity, and positive predictive value relative to DSM5 criteria. The protocol was IRB approved and powered to detect ≥80% sensitivity with 95% confidence.

Clinical and public health implications

• Pent up demand: an estimated 17 million American adults have ADHD, yet waiting lists for specialist evaluation can exceed six months.

• Telehealth preference: CDC data indicate 46% of U.S. adults with ADHD already use telehealth services. Until now, no online assessment had been validated.

• Health equity impact: Digital, asynchronous tools remove geographic and scheduling barriers, enabling evidence based diagnosis for rural, underserved, and shift working populations. 

Executive comments

“Publication in a top-tier peer-review journal moves this evidence base forward, for our diagnostic evaluation specifically and for telehealth in general,” said Barry K. Herman, MD, MMM, chief medical officer at Mentavi Health and first author of the paper. “The study shows that an online ADHD diagnosis can be accurately assessed asynchronously, closing gaps in care created by specialist shortages and long waitlists.”

Andrew J. Cutler, MD, chief medical officer at the Neuroscience Education Institute, clinical associate professor of psychiatry at SUNY Upstate Medical University, and study co-author, commented: “As one of the first large peer-reviewed evaluations of a telehealth ADHD tool, this paper will shape guidelines and payer policies worldwide.”

“Publication in the JCP sets a new standard for evidence-based digital mental health,” added Keith Brophy, CEO of Mentavi Health. “It validates years of work to build a rigorous online diagnostic platform and expands our mission to remove barriers of access to accurate mental-health assessments.”

Where to learn more

• Peer-reviewed validation study, open access: The Journal of Clinical Psychiatry

• Article title: Validity of an Online Assessment of Attention Deficit/Hyperactivity Disorder Among a RealWorld Sample of Adults Seeking Web Based Mental Health Care (open access)

• Byline: Barry K. Herman, MD, MMM; Stephen V. Faraone, PhD; Andrew J. Cutler, MD; Jeffrey H. Newcorn, MD; Emily M. LaFrance, PhD; Michelle Ripper Lewis, BSN, RN; Charles Ruetsch, PhD

• Citation: J Clin Psychiatry. 2025;86(3):25m15846

• DOI: 10.4088/JCP.25m15846

About Mentavi Health and ADHD Online

Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Mental Health Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, compliant online mental health care. For more information, visit mentavi.com.

Contact Information

Tim Cox
ZingPR for Mentavi
tim@zingpr.com

Related Video

https://www.youtube.com/watch?v=N6Xd9UJRO9s

SOURCE: Mentavi Health

Related Images

View the original press release on ACCESS Newswire

Early Patient Feedback Points to Clearer Understanding of Results and Smoother Treatment Planning

GRAND RAPIDS, MICHIGAN / ACCESS Newswire / October 1, 2025 / Quintessence Psychiatry, a telepsychiatry practice led by Nona Kocher, MPH, MD, has adopted Mentavi Health‘s asynchronous Diagnostic Evaluation to offer patients a scientifically rigorous, accessible alternative to full neuropsychological testing. The Mentavi Diagnostic Evaluation is clinically validated (and now peer-reviewed and published in the The Journal of Clinical Psychiatry*) for the diagnosis of ADHD in adults.

Quintessence Psychiatry previously referred ADHD inquiries to external neuropsychology providers – a process that can involve weeks to months of waiting and hundreds of dollars in testing costs for a broad battery of tests many patients don’t need. Early experiences at Quintessence show patients can complete the self-directed evaluation at their convenience (often at home) and return to the clinic with a report reviewed by a licensed psychologist to guide treatment conversations.

“Mentavi gives my patients a focused, evidence-based ADHD evaluation at a price and speed they can actually use,” said Dr. Nona Kocher, psychiatrist and founder of Quintessence Psychiatry. “It adds rigor to my workflow and helps patients understand what the findings mean, so we can move forward with an informed plan rather than sending them into a lengthy outside testing queue.”

In the initial phase of adoption, three patients have completed the evaluation, with positive feedback on the clarity of the results and visuals. Patients typically review the Mentavi report with Dr. Kocher at a follow-up visit to discuss how ADHD symptoms may be affecting daily life and to consider therapy and/or medication options. “The report graphics make it easier for patients to grasp their results at a glance, which improves shared decision making,” Dr. Kocher added.

Beyond speed and accessibility, the Mentavi Diagnostic Evaluation integrates cleanly into Quintessence’s care model, which emphasizes applying modern, science-based methods – including, when appropriate, pharmacogenetic testing – to reduce trial and error in treatment selection.

“We are pleased that our validated diagnostic approach can serve Quintessence Psychiatry by removing barriers to timely access to care for their patients. This is what our approach was designed for,” said Keith Brophy, CEO of Mentavi Health.

“Clinicians like Dr. Kocher tell us Mentavi helps them triage ADHD inquiries efficiently and focus their time where it matters most – on individualized care,” said Mentavi Health Chief Medical Officer Barry K. Herman, M.D., MMM. “We’re pleased to support private practices with an evaluation that is clinically validated, rigorous, patient-friendly, and easy to fold into existing workflows.”

Quintessence intends to continue offering the Mentavi Diagnostic Evaluation for appropriate ADHD cases and to gather ongoing patient feedback to inform clinical workflows.

* Peer‑reviewed validation: Results of Mentavi’s diagnostic validation study were published in The Journal of Clinical Psychiatry on September 8, 2025 (J Clin Psychiatry 2025;86(3):25m15846; doi:10.4088/JCP.25m15846).

About Quintessence Psychiatry

Quintessence Psychiatry is a patient-centered telepsychiatry practice led by Nona Kocher, MD, offering comprehensive evaluations, medication management, and individualized care plans. The practice integrates modern, evidence-based methods to help patients move from assessment to actionable next steps. For more information, visit quintessencepsychiatry.com.

About Mentavi Health

Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, and compliant online mental health care, grounded in clinical validation and trust. For more information, visit mentavi.com.

Contact Information

Tim Cox
ZingPR for Mentavi
tim@zingpr.com

SOURCE: Mentavi Health

Related Images

View the original press release on ACCESS Newswire